Levels of the oxidative stress marker γ-Glutamyltranspeptidase at different stages of nonalcoholic fatty liver disease

Journal of International Medical Research

Volumn 40, Issue 3, 2012, Pages 924-933

  Irie, M ^a   Sohda, T ^a   Iwata, K ^a   Kunimoto, H ^a   Fukunaga, A ^a   Kuno, S ^a   Yotsumoto, K ^a   Sakurai, K ^a   Iwashita, H ^a   Hirano, G ^a   Ueda, Si ^a   Yokoyama, K ^a   Morihara, D ^a   Nishizawa, S ^a   Anan, A ^a   Takeyama, Y ^a   Sakamoto, M ^a   Shakado, S ^a   Sakisaka, Shotaro ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Alcoholic liver disease; Fatty liver; G Glutamyltranspeptidase; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Oxidative stress

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; FERRITIN; GAMMA GLUTAMYLTRANSFERASE; GLYCOSYLATED HEMOGLOBIN; INSULIN; IRON; TRIACYLGLYCEROL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALCOHOL LIVER DISEASE; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FERRITIN BLOOD LEVEL; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INSULIN BLOOD LEVEL; IRON BLOOD LEVEL; LIVER BIOPSY; MALE; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84863086904     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001204000311     Document Type: Article

References (32)

1. Ludwig J, Viggiano TR, McGill DB, et al: Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980; 55: 434-438.
2. Shulman AI, Mangelsdorf DJ: Retinoid X receptor heterodimers in the metabolic syndrome. N Engl J Med 2005; 353: 604-615.
3. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-A: direct role in obesity-linked insulin resistance. Science 1993; 259: 87-91.
4. Day CP, James OF: Steatohepatitis: a tale of two "hits"? Gastroenterology 1998; 114: 842-845.
5. Krawczyk M, Bonfrate L, Portincasa P: Nonalcoholic fatty liver disease. Best Pract Res Clin Gastroenterol 2010; 24: 695-708.
6. Floyd RA, West MS, Eneff KL, et al: Hydroxyl free radical mediated formation of 8-hydroxyguanine in isolated DNA. Arch Biochem Biophys 1988; 262: 266-272.
7. Kasai H, Crain PF, Kuchino Y, et al: Formation of 8-hydroxyguanine moiety in cellular DNA by agents producing oxygen radicals and evidence for its repair. Carcinogenesis 1986; 7: 1849-1851.
8. Seki S, Kitada T, Yamada T, et al: In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. J Hepatol 2002; 37: 56-62.
9. Evans MD, Cooke MS, Podmore ID, et al: Discrepancies in the measurement of UVCinduced 8-oxo-28-deoxyguanosine: implications for the analysis of oxidative DNA damage. Biochem Biophys Res Commun 1999; 259: 374-378.
10. Toyokuni S, Tanaka T, Hattori Y, et al: Quantitative immunohistochemical determina-tion of 8-hydroxy-2t-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcino-genesis model. Lab Invest 1997; 76: 365-374.
11. Meister A, Tate SS, Griffith OW: γ-Glutamyl transpeptidase. Methods Enzymol 1981; 77: 237-253.
12. Taniguchi N, Yososawa N, Iizuka S, et al: γ-Glutamyl transpeptidase of rat liver and hepatoma tissues: an enzyme immunoassay and immunostaining studies. Ann NY Acad Sci 1983; 417: 203-212.
13. Whitfield JB: Gamma glutamyl transferase. Crit Rev Clin Lab Sci 2001; 38: 263-355.
14. Spencer-Peet J, Wood D, Glatt MM: Gammaglutamyl transpeptidase in alcoholism. Lancet 1972; 20: 1122-1123.
15. Poulsen HE, Prieme H, Loft S: Role of oxidative DNA damage in cancer initiation and promotion. Eur J Cancer Prev 1998; 7: 9-16.
16. Banderas DZ, Escobedo J, Gonzalez E, et al: γ-Glutamyl transferase: a marker of nonalcoholic fatty liver disease in patients with the metabolic syndrome. Eur J Gastroenterol Hepatol 2012; Epub ahead of print.
17. Kang YH, Min HK, Son SM, et al: The association of serum gamma glutamyltransferase with components of the metabolic syndrome in the Korean adults. Diabetes Res Clin Pract 2007; 77: 306-313.
18. Saito S, Yamauchi H, Hasui Y, et al: Quantitative determination of urinary 8-hydroxydeoxyguanosine (8-OH-dG) by using ELISA. Res Commun Mol Pathol Pharmacol 2000; 107: 39-44.
19. Forlenza MJ, Miller GE: Increased serum levels of 8-hydroxy-2o-deoxyguanosine in clinical depression. Psychosom Med 2006; 68: 1-7.
20. Ota T, Takamura T, Kurita S, et al: Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis. Gastroenterology 2007; 132: 282-293.
21. Rolo AP, Teodoro JS, Palmeira CM: Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic Biol Med 2012; 52: 59-69.
22. Le TH, Caldwell SH, Redick JA, et al: The zonal distribution of megamitochondria with crystalline inclusions in nonalcoholic steatohepatitis. Hepatology 2004; 39: 1423-1429.
23. Kamada Y, Takehara T, Hayashi N: Adipocytokines and liver disease. J Gastroenterol 2008; 43: 811-822.
24. Wigg AJ, Roberts-Thomson IC, Dymock RB, et al: The role of small intestinal bacterial overgrowth, intestinal permeability, endo-toxaemia, and tumour necrosis factor ttin the pathogenesis of non-alcoholic steato hepatitis. Gut 2001; 48: 206-211.
25. Tokushige K, Takakura M, Tsuchiya-Matsushita N, et al: Influence of TNF gene polymorphisms in Japanese patients with NASH and simple steatosis. J Hepatol 2007; 46: 1104-1110.
26. Mitsuyoshi H, Yasui K, Harano Y, et al: Analysis of hepatic genes involved in the metabolism of fatty acids and iron in nonalcoholic fatty liver disease. Hepatol Res 2009; 39: 366-373.
27. Tsuchiya H, Akechi Y, Ikeda R, et al: Suppressive effects of retinoids on iron-induced oxidative stress in the liver. Gastroenterology 2009; 136:341-350. e8.
28. Baskol G, Baskol M, Kocer D: Oxidative stress and antioxidant defenses in serum of patients with non-alcoholic steatohepatitis. Clin Biochem 2007; 40: 776-780.
29. Smith BW, Adams LA: Non-alcoholic fatty liver disease. Crit Rev Clin Lab Sci 2011; 48: 97-113.
30. Machado MV, Ravasco P, Jesus L, et al: Blood oxidative stress markers in non-alcoholic steatohepatitis and how it correlates with diet. Scand J Gastroenterol 2008; 43: 95-102.
31. Irie M, Suzuki N, Sohda T, et al: Hepatic expression of gamma-glutamyltranspeptidase in the human liver of patients with alcoholic liver disease. Hepatol Res 2007; 37: 966-973.
32. Takigawa T, Hibino Y, Kimura S, et al: Association between serum γ-glutamyl-transferase and oxidative stress related factors. Hepatogastroenterology 2008; 55: 50-53.